Laurus Labs jumps on getting EIR for API manufacturing facility in Andhra Pradesh

15 Apr 2025 Evaluate

Laurus Labs is currently trading at Rs. 619.60, up by 13.50 points or 2.23% from its previous closing of Rs. 606.10 on the BSE.

The scrip opened at Rs. 613.75 and has touched a high and low of Rs. 623.40 and Rs. 609.00 respectively. So far 93159 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 646.25 on 07-Feb-2025 and a 52 week low of Rs. 386.85 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 623.40 and Rs. 517.05 respectively. The current market cap of the company is Rs. 33487.58 crore.

The promoters holding in the company stood at 27.62%, while Institutions and Non-Institutions held 38.30% and 34.08% respectively.

Laurus Labs has received the Establishment Inspection Report (EIR) for its API manufacturing facility Unit-4, Atchutapuram, Anakapalli District (Visakhapatnam), Andhra Pradesh. The United States Food & Drug Administration (USFDA) inspection was conducted from January 27, 2025 to January 31, 2025. 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

612.35 -34.80 (-5.38%)
25-Apr-2025 10:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.55
Dr. Reddys Lab 1170.05
Cipla 1524.00
Lupin 2041.00
Zydus Lifesciences 860.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...